A case of successful surgical management of primary retroperitoneal mucinous cystadenoma

Primary retroperitoneal mucinous cystadenoma in a female patient: A case report

Introduction

Primary retroperitoneal mucinous cystadenoma is an extremely uncommon tumor occurring mostly in females. The histogenesis of PRMC remains unclear and Open surgery is the most impressive treatment.

Case presentation

We present a 20-year-old Iranian woman with history of intermittent abdominal pain. In physical examination, her abdomen had a mildly asymmetrical distention and a round shape mass was palpated in right abdomen also she had a mild tenderness in right abdomen. Radiologic assessment revealed a right retroperitoneal smooth cystic mass (20 × 15 cm) without invasive features. The patient underwent complete surgical excision of the tumor by a laparotomic approach because of its size. The lesion was gently dissected from the contiguous organs and removed completely without spillage of its content. In microscopic investigations, sections showed a unilocular cyst with fibrous wall lined via monolayered bland looking columnar mucinous epithelium and no atypia or stromal invasion was presented. Diagnosis of a PRMC was made. The patient has discharged without any complications in 2 days' postoperative course.

Discussion

Generally, cysts are asymptomatic and are found fortuitously after a routine checkup assessment. Symptoms and signs related to this cyst are mainly because of their huge size and compression effect. Radiological assessments are effective in specifying the lesion preoperatively; although, the final diagnosis always needs histopathological verification.

Conclusion

When the tumor is diagnosed, full resection should be considered because of the infectious or malignant potential of the tumor.

•

Full resection of retroperitoneal mucinous cystadenoma because of the infectious or malignant potential of the tumor

•

Histological and macroscopical likeness of primary retroperitoneal cystadenoma to ovarian mucinous cystadenoma

•

CK7 and CA125 positivity in retroperitoneal mucinous cystadenoma because of its Mullerian origin

•

Symptoms and signs related to the cyst mainly because of its huge size and compression effect

Mixed serous and mucinous retroperitoneal cystadenoma: an extremely rare case

Mixed serous and mucinous retroperitoneal cyst adenoma is an extremely rare condition as most of the reported cases in the literature are primary retroperitoneal mucinous cystadenomas and primary retroperitoneal serous cystadenomas. They are initially asymptomatic and become symptomatic gradually depending on their size and anatomical extension and location. We report a 49-year-old woman with a history of right-side abdomen pain for a few years. Diagnostic images revealed a large retroperitoneal cystic lesion. A laparoscopic resection was performed without spillage. The patient was discharged without complication postoperatively and no recurrence on follow-up. Surgical excision, either open/or laparoscopic without any spillage, remains the most effective and appropriate treatment for this lesion.

Clinical characteristics, treatment strategies and oncologic outcomes of primary retroperitoneal tumours: a retrospective analysis in the Chinese population

INTRODUCTION

Primary retroperitoneal tumours (PRTs) are rare soft tissue tumours originating from the retroperitoneum. Although there has been considerable progress recently in diagnosis and treatment, the overall survival rate has not improved qualitatively. This study aimed to explore the clinical features, therapeutic strategies and prognosis of PRTs.

METHODS

Retrospective analysis of clinical data for 121 PRT patients admitted to Peking University Shenzhen Hospital from April 2003 to February 2017.

RESULTS

A total of 113 patients underwent surgery and 8 chose nonsurgical palliative treatment. There were 53 males and 68 females (ratio, 1:1.3; average age, 40.75 years), and the average tumour diameter was 9.69(2-40)cm. A total of 104 patients (92.04%) underwent complete resection, 5 (4.42%) underwent palliative resection and 21 (18.58%) underwent combined visceral resection. The pathological diagnosis was benign in 88 cases (72.73%) and malignant in 33 cases (27.27%). A total of 101 patients (83.47%) were followed for an average of 5.82 years. At the end of follow up, the recurrence and survival rates were 2.63% and 93.42% for benign tumours, respectively, and 24.00% and 60.00% for malignant tumours (p<0.01).

CONCLUSIONS

Imaging plays important roles in localising and characterising tumours, guiding treatment strategies. Complete tumour resection is key to reducing postoperative recurrence and improving survival. According to the postsurgical pathological results, combinations including radiotherapy, chemotherapy or targeted therapy are beneficial for improving prognosis.